开发高效的酸/聚苏胺基水凝作为可生物降解的乙氨基输送系统
Long Toan Trinh1, Saebin Lim1, Hyun Jong Lee1
1Department of Chemical and Biological Engineering, Gachon University, Seongnam-si 13120, Republic of Korea.
Gels (Basel, Switzerland)
|December 22, 2023
概括
这项研究开发了新型的甲基酸盐/聚苏胺 (PSI) 水凝,用于有效的乙氨基 (AP) 输送. 这些水凝可以每天服用一次,通过在24小时内持续释放AP,改善患者的治疗结果.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 聚合物化学 聚合物化学
背景情况:
- 口服乙氨基 (AP) 需要频繁的管理 (大约. 每天4次),造成过量服用和频繁使用的风险.
- 开发高效的药物输送系统对于提高患者的治疗结果和治疗疗效至关重要.
- 可生物降解的聚合物为更安全,更有效的药物给药途径提供了潜力.
研究的目的:
- 开发一种高效的,每天一次的乙氨基 (AP) 药物输送系统.
- 创建新的酸盐和多素胺 (PSI) 水凝,以持续释放AP.
- 评估水凝的特性,包括机械强度,药物溶解,生物降解性和释放概况.
主要方法:
- 制造基酸盐/PSI水凝.
- 水凝机械性能的表征.
- 评估药物溶解和释放动力学.
- 通过肠道水解评估PSI的生物降解性.
主要成果:
- 开发的水凝表现出改善的结构机械性能.
- 在肠道中PSI的水解有助于药物完全溶解和排出.
- 水凝在24小时内持续释放AP.
- 持续释放的特征表明,有可能每天服用一次剂量.
结论:
- 基酸盐/PSI水凝作为乙氨基 (AP) 的可生物降解输送系统具有前景.
- 这些水凝可能会降低剂量频率,并改善患者的遵守性.
- 这些发现对开发各种治疗剂的先进药物输送系统有影响.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...


